Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Galectin Therapeutics Inc (GALT)  
$2.39 0.02 (0.83%) as of 4:30 Thu 3/28


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 57,080,000
Market Cap: 136.42(M)
Last Volume: 97,895 Avg Vol: 97,616
52 Week Range: $1.32 - $2.44
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:

    AMEX COMPOSITE

Rankings:

     
Insider 3 Months    : 1.9
Insider 6 Months    : 1.9
Insider 3/6 Months : 4.2
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 500 500 2,098 39,398
Total Buy Value $893 $893 $3,747 $63,406
Total People Bought 1 1 1 5
Total Buy Transactions 1 1 2 11
Total Shares Sold 0 0 0 20,000
Total Sell Value $0 $0 $0 $41,740
Total People Sold 0 0 0 2
Total Sell Transactions 0 0 0 2
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 511
  Page 1 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Lewis Joel President and CEO   •       •      –    2024-03-01 4 A $1.96 $299,065 D/D 152,584 897,716     -
   Uihlein Richard E   •       •       •   2024-01-24 4 A $1.72 $40,000 D/D 23,256 10,268,751     -
   Eldred Kary   •       •      –    2024-01-16 4 B $1.79 $893 D/D 500 49,313 0.01 32%     
   Lewis Joel President and CEO   •       •      –    2023-12-29 4 A $1.66 $19,266 D/D 11,606 1,042,300     -
   Lewis Joel President and CEO   •       •      –    2023-12-15 4 A $1.60 $19,267 D/D 12,042 1,030,694     -
   Lewis Joel President and CEO   •       •      –    2023-11-30 4 A $1.95 $19,266 D/D 9,880 1,018,652     -
   Lewis Joel President and CEO   •       •      –    2023-11-15 4 A $1.87 $19,267 D/D 10,303 1,008,772     -
   Lewis Joel President and CEO   •       •      –    2023-10-31 4 A $2.04 $19,266 D/D 9,444 998,469     -
   Lewis Joel President and CEO   •       •      –    2023-10-13 4/A A $2.01 $19,266 D/D 9,585 989,025     -
   Lewis Joel President and CEO   •       •      –    2023-10-13 4 A $2.01 $20,170 D/D 10,035 989,025     -
   Lewis Joel President and CEO   •       •      –    2023-09-29 4 A $1.92 $19,267 D/D 10,035 979,440     -
   Uihlein Richard E   •       •       •   2023-09-26 4 OE $3.00 $10,033,020 D/D 2,236,204 10,235,495     -
   Lewis Joel President and CEO   •       •      –    2023-09-15 4 A $1.76 $19,267 D/D 10,947 969,405     -
   Lewis Joel President and CEO   •       •      –    2023-08-15 4 A $1.60 $19,267 D/D 12,042 947,448     -
   Lewis Joel President and CEO   •       •      –    2023-07-31 4 A $1.50 $19,266 D/D 12,844 935,406     -
   Eldred Kary   •       •      –    2023-07-19 4 B $1.79 $2,854 D/D 1,598 48,813 0.01 24%     
   Lewis Joel President and CEO   •       •      –    2023-07-14 4 A $1.63 $19,267 D/D 11,820 922,562     -
   Lewis Joel President and CEO   •       •      –    2023-06-30 4 A $1.44 $19,267 D/D 13,380 911     -
   Lewis Joel President and CEO   •       •      –    2023-06-15 4 A $1.46 $19,266 D/D 13,196 897,362     -
   Lewis Joel President and CEO   •       •      –    2023-05-31 4 A $1.57 $19,267 D/D 12,272 884,166     -
   Lewis Joel President and CEO   •       •      –    2023-05-15 4 A $1.64 $19,267 D/D 11,748 871,894     -
   Lewis Joel President and CEO   •       •      –    2023-04-28 4 A $1.76 $19,267 D/D 10,947 860,146     -
   Lewis Joel President and CEO   •       •      –    2023-04-14 4 A $2.01 $19,266 D/D 9,585 849,199     -
   Lewis Joel President and CEO   •       •      –    2023-03-15 4 A $1.90 $19,266 D/D 10,140 830,439     -
   Lewis Joel President and CEO   •       •      –    2023-03-01 4 D $2.07 $156,345 D/D (75,529) 820,299     -

  511 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed